Protalix BioTherapeutics
PLX
#8687
Rank
A$0.25 B
Marketcap
A$3.11
Share price
1.42%
Change (1 day)
-24.18%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): A$0.02312

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is A$0.02910. In 2024 the company made an earnings per share (EPS) of A$0.05820 a decrease over its 2023 EPS that were of A$0.17.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.02312-60.28%
2024A$0.05820-66.67%
2023A$0.17-138.71%
2022A-$0.45-50%
2021A-$0.90181.82%
2020A-$0.32-82.11%
2019A-$1.79-31.67%
2018A-$2.62-72.31%
2017A-$9.46124.14%
2016A-$4.22-147.54%
2015A$8.88-290.62%
2014A-$4.666.67%
2013A-$4.36130.77%
2012A-$1.89-69.77%
2011A-$6.2619.44%
2010A-$5.24-12.2%
2009A-$5.9736.67%
2008A-$4.36-37.5%
2007A-$6.9850%
2006A-$4.663.23%
2005A-$4.51138.46%
2004A-$1.89-74%
2003A-$7.27-0%
2002A-$7.27-50%
2001A-$14.55233.33%
2000A-$4.36-84.21%
1999A-$27.64-24%
1998A-$36.37-600%
1997A$7.27-16.67%
1996A$8.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.98 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$7.01 24,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.16-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.80 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel